Author

Shweta Kadu

Institution: Prashanti Cancer Care Mission

Observed institutions: Indian Institute of Science Education and Research Pune, Abasaheb Garware College, Prashanti Cancer Care Mission

ORCID: 0000-0001-9135-5285

Observed ORCID: 0000-0001-9135-5285

OpenAlex ID: A5069836234

Therapeutic mammoplasty: a “wise” oncoplastic choice—lessons from the largest single-center cohort from Asia

2023 · Chaitanyanand Koppiker, Sneha Joshi, et al. · Frontiers in Oncology · 11

Impact of oncoplasty in increasing breast conservation rates Post neo-adjuvant chemotherapy

2023 · Chaitanyanand B. Koppiker, Devaki A. Kelkar, et al. · Frontiers in Oncology · 8

EGFR and AR expression and co-expression in Indian triple-negative breast cancer with patient outcome association

2026 · Pooja Vaid, Anirudha Puntambekar, et al. · Scientific Reports · 3

Into the thirteenth Month: A Case Study on the Outbreak Analytics and Modeling the spread of SARS-CoV-2 Infection in Pune City, India

2021 · Joy Monteiro, Bhalchandra Pujari, et al. · medRxiv · 2

An Audit of Triple-Negative Breast Cancer (TNBC) Management at a Tertiary Breast Cancer Care Center in India

2024 · Bindusha Das, Shweta Kadu, et al. · Indian Journal of Surgical Oncology

The Implementation of Donation System using Blockchain

2023 · Prof. Vilas Jadhav, Shweta Kadu, et al. · International Journal of Advanced Research in Science Communication and Technology

Therapeutic mammoplasty as a viable surgical approach in Breast Cancer Patients from India: A Single Institutional Audit

2021 · C. B. Koppiker, Sneha Joshi, et al. · medRxiv

Works count: 7

Citation count: 24

H-index: 3

I10-index: 1